Page last updated: 2024-10-31

midazolam and Ductus Arteriosus, Patent

midazolam has been researched along with Ductus Arteriosus, Patent in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Ductus Arteriosus, Patent: A congenital heart defect characterized by the persistent opening of fetal DUCTUS ARTERIOSUS that connects the PULMONARY ARTERY to the descending aorta (AORTA, DESCENDING) allowing unoxygenated blood to bypass the lung and flow to the PLACENTA. Normally, the ductus is closed shortly after birth.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pivalizza, EG1
Ando, KJ1
Sweeney, MS1

Other Studies

1 other study available for midazolam and Ductus Arteriosus, Patent

ArticleYear
Kearns-Sayre syndrome and cardiac anesthesia.
    Journal of cardiothoracic and vascular anesthesia, 1995, Volume: 9, Issue:2

    Topics: Adult; Anesthesia, Intravenous; Aortic Coarctation; Aortic Valve; Cardiac Surgical Procedures; Cardi

1995